Mykhaloiko, I. and Yatsyshyn, R. 2026. Apixaban versus warfarin in nephrotic syndrome: thromboembolic events, bleeding risk and changes in profibrotic and inflammatory cytokines. Ukrainian Journal of Nephrology and Dialysis. 2(90) (Jun. 2026), 20-31. DOI:https://doi.org/10.31450/ukrjnd.2(90).2026.03.